The Independent has unveiled its 2026 Pride programme, expanding its commitment to LGBTQ+ voices.

Gilead Sciences gears up for Q1 earnings with HIV drugs driving growth, but cell therapy headwinds and rising costs could shape the outlook.

After thirty years, plenty of therapy, a clothing-optional resort, and a near-divorce, we now have a sex life we never could ...

It was there, while Muluba was only two years old, that she and her mother were diagnosed as HIV positive. As a child, her mother tried to protect her by insisting that she couldn ...

The Food Chain, the UK’s only HIV specialist nutrition charity, has received a £5,000 grant to support its Eating Together ...

The US still delivered HIV treatment, in the form of antiretroviral drugs, to about 20 million people from July through ...

In this era of the HIV epidemic, talking saves lives. It pierces stigma and turns ordinary conversation into something ...

Brenton Williams finally felt he had the proper health insurance to ask his doctor about PrEP (Pre-Exposure Prophylaxis), a ...

Zaven Boyrazian explains why retail investors are rushing to buy this FTSE 100 pharmaceutical giant and explores whether now's the time to buy.

Only two men in the UK have been convicted for deliberately infecting men with HIV - and they're both from the North East ...

The youngest victim of predator Adam Hall was told he was HIV-positive just after he climbed off the school bus. Now 22, they ...